Telix share price lifts off on big US FDA news
Image source: Getty Images
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today.
Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.60. In earlier trade shares were up more than 10%. At the time of writing in late morning trade on Tuesday, shares are changing hands for $14.29 apiece, up 5.1%.
For some context, the ASX 200 is down 0.5% at this same time.
This outperformance of the Telix share price follows a promising development with the United States Food and Drug Administration (FDA).
Here’s what is grabbing ASX investor interest.
Telix share price soars on FDA agreement
The Telix share price is enjoying a boost after the company announced…
